Precision BioSciences Inc (DTIL)
7.62
-0.08
(-1.04%)
USD |
NASDAQ |
Nov 15, 16:00
7.60
-0.02
(-0.26%)
After-Hours: 20:00
Precision BioSciences Research and Development Expense (TTM): 57.04M for Sept. 30, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2024 | 57.04M |
| June 30, 2024 | 59.81M |
| March 31, 2024 | 55.67M |
| December 31, 2023 | 53.38M |
| September 30, 2023 | 52.67M |
| June 30, 2023 | 48.58M |
| March 31, 2023 | 58.42M |
| December 31, 2022 | 67.35M |
| September 30, 2022 | 81.14M |
| June 30, 2022 | 95.32M |
| March 31, 2022 | 109.62M |
| December 31, 2021 | 115.24M |
| Date | Value |
|---|---|
| September 30, 2021 | 111.89M |
| June 30, 2021 | 110.83M |
| March 31, 2021 | 98.78M |
| December 31, 2020 | 98.06M |
| September 30, 2020 | 94.84M |
| June 30, 2020 | 89.76M |
| March 31, 2020 | 87.33M |
| December 31, 2019 | 82.42M |
| September 30, 2019 | 78.91M |
| June 30, 2019 | 68.86M |
| March 31, 2019 | 56.97M |
| December 31, 2018 | 45.12M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
48.58M
Minimum
Jun 2023
115.24M
Maximum
Dec 2021
81.41M
Average
84.88M
Median
Research and Development Expense (TTM) Benchmarks
| Pfizer Inc | 10.60B |
| Assembly Biosciences Inc | 49.97M |
| Protagonist Therapeutics Inc | 132.12M |
| Alector Inc | 187.20M |
| Entrada Therapeutics Inc | 120.19M |